A, K., M, S., & PR, B. (2009). Cascade impactor practice for a high dose dry powder inhaler at 90 L/min: NGI versus modified 6-stage and 8-stage ACI. Journal of pharmaceutical sciences, 98(3), 1028. https://doi.org/10.1002/jps.21501
Chicago Style (17th ed.) CitationA, Kamiya, Sakagami M, and Byron PR. "Cascade Impactor Practice for a High Dose Dry Powder Inhaler at 90 L/min: NGI Versus Modified 6-stage and 8-stage ACI." Journal of Pharmaceutical Sciences 98, no. 3 (2009): 1028. https://doi.org/10.1002/jps.21501.
MLA (9th ed.) CitationA, Kamiya, et al. "Cascade Impactor Practice for a High Dose Dry Powder Inhaler at 90 L/min: NGI Versus Modified 6-stage and 8-stage ACI." Journal of Pharmaceutical Sciences, vol. 98, no. 3, 2009, p. 1028, https://doi.org/10.1002/jps.21501.